The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress

Current Neuropharmacology

Volumn 10, Issue 4, 2012, Pages 328-343

  Martinc, Boštjan ^a   Grabnar, Iztok ^a   Vovk, Tomaž ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Antiepileptic drugs; Antioxidants; Calcium; Epileptogenesis; Mitochondria; Oxidative stress; Reactive species; Signalling

Indexed keywords

ALPHA TOCOPHEROL; ANTICONVULSIVE AGENT; CALCIUM; CARBAMAZEPINE; CATALASE; CYTOKINE; ETIRACETAM; FREE RADICAL; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 2 RECEPTOR ALPHA; LAMOTRIGINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NITRIC OXIDE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TOPIRAMATE; TRIMETAZIDINE; VALPROIC ACID; ZONISAMIDE;

ANTIOXIDANT ACTIVITY; ASTROCYTE; CELL DAMAGE; CELL DEATH; COVALENT BOND; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; HOMEOSTASIS; HUMAN; IMMUNOREACTIVITY; MACROMOLECULE; NERVE CELL; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RECURRENT DISEASE; REVIEW; SEIZURE; TISSUE INJURY; UNSPECIFIED SIDE EFFECT;

EID: 84874854170     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/157015912804499447     Document Type: Review

References (137)

1. Delgado-Escueta, A.V. Symptomatic lesional epilepsies. In: Jasper's Basic Mechanisms of the Epilepsies. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999, 433-436.
2. Stefan, H.; Halasz, P.; Gil-Nagel, A.; Shorvon, S.; Bauer, G.; Ben-Menachem, E.; Perucca, E.; Wieser, H.G.; Steinlein, O. Recent advances in the diagnosis and treatment of epilepsy. Eur. J. Neurol., 2001, 8(6), 519-539.
3. Patel, M. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic. Biol. Med., 2004, 37(12), 1951-1962.
4. Scott, R.A.; Lhatoo, S.D.; Sander, J.W. The treatment of epilepsy in developing countries: where do we go from here? Bull. World Health Organ, 2001, 79(4), 344-351.
5. Victor, M.; Ropper, A. Adams and Victor's principles of neurology, 7th ed. New York. McGraw Hill, 2001, 331-332.
6. Bromfield, E.B.; Cavazos, J.E.; I., J.I.S.J. Chapter 1. Basic Mechanisms Underlying Seizures and Epilepsy. In: An Introduction to Epilepsy. West Hartford (CT): American Epilepsy Society; 2006, 1-26.
7. Delorenzo, R.J.; Sun, D.A.; Deshpande, L.S. Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol. Ther., 2005, 105(3), 229-266.
8. Pitkanen, A.; Sutula, T.P. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol., 2002, 1(3), 173-181.
9. Pitkanen, A.; Lukasiuk, K. Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav., 2009, 14 Suppl 1, 16-25.
10. Scharfman, H.E. The neurobiology of epilepsy. Curr. Neurol. Neurosci. Rep., 2007, 7(4), 348-354.
11. Guerrini, R.; Casari, G.; Marini, C. The genetic and molecular basis of epilepsy. Trends Mol. Med., 2003, 9(7), 300-306.
12. Ferriero, D.M. Protecting neurons. Epilepsia, 2005, 46 Suppl 7, 45-51.
13. Haut, S.R.; Veliskova, J.; Moshe, S.L. Susceptibility of immature and adult brains to seizure effects. Lancet Neurol., 2004, 3(10), 608-617.
14. Henshall, D.C.; Simon, R.P. Epilepsy and apoptosis pathways. J. Cereb. Blood Flow Metab., 2005, 25(12), 1557-1572.
15. Chuang, Y.C. Mitochondrial dysfunction and oxidative stress in seizure-induced neuronal cell death. Acta Neurol Taiwan, 2010, 19(1), 3-15.
16. Willmore, L.J.; Ueda, Y. Posttraumatic epilepsy: hemorrhage, free radicals and the molecular regulation of glutamate. Neurochem. Res., 2009, 34(4), 688-697.
17. Rosen, A.D.; Frumin, N.V. Focal epileptogenesis after intracortical hemoglobin injection. Exp. Neurol., 1979, 66(2), 277-284.
18. Gupta, Y.K.; Gupta, M. Post traumatic epilepsy: a review of scientific evidence. Indian J. Physiol. Pharmacol., 2006, 50(1), 7-16.
19. Shin, C.; McNamara, J.O. Mechanism of epilepsy. Annu. Rev. Med., 1994, 45, 379-389.
20. Liang, L.P.; Ho, Y.S.; Patel, M. Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience, 2000, 101(3), 563-570.
21. Xavier, S.M.; Barbosa, C.O.; Barros, D.O.; Silva, R.F.; Oliveira, A.A.; Freitas, R.M. Vitamin C antioxidant effects in hippocampus of adult Wistar rats after seizures and status epilepticus induced by pilocarpine. Neurosci. Lett., 2007, 420(1), 76-79.
22. Yamamoto, H.A.; Mohanan, P.V. Ganglioside GT1B and melatonin inhibit brain mitochondrial DNA damage and seizures induced by kainic acid in mice. Brain Res., 2003, 964(1), 100-106.
23. Waldbaum, S.; Patel, M. Mitochondrial dysfunction and oxidative stress: a contributing link to acquired epilepsy? J. Bioenerg. Biomembr., 2010, 42(6), 449-455.
24. Blair, R.E.; Sombati, S.; Lawrence, D.C.; McCay, B.D.; DeLorenzo, R.J. Epileptogenesis causes acute and chronic increases in GABAA receptor endocytosis that contributes to the induction and maintenance of seizures in the hippocampal culture model of acquired epilepsy. J. Pharmacol. Exp. Ther., 2004, 310(3), 871-880.
25. Morris, T.A.; Jafari, N.; Rice, A.C.; Vasconcelos, O.; DeLorenzo, R.J. Persistent increased DNA-binding and expression of serum response factor occur with epilepsy-associated long-term plasticity changes. J. Neurosci., 1999, 19(19), 8234-8243.
26. Brookes, P.S.; Levonen, A.L.; Shiva, S.; Sarti, P.; Darley-Usmar, V.M. Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic. Biol. Med., 2002, 33(6), 755-764.
27. McCormack, J.G.; Denton, R.M. Mitochondrial Ca2+ transport and the role of intramitochondrial Ca2+ in the regulation of energy metabolism. Dev. Neurosci., 1993, 15(3-5), 165-173.
28. Perez-Campo, R.; Lopez-Torres, M.; Cadenas, S.; Rojas, C.; Barja, G. The rate of free radical production as a determinant of the rate of aging: evidence from the comparative approach. J. Comp. Physiol. B, 1998, 168(3), 149-158.
29. Brookes, P.S.; Yoon, Y.; Robotham, J.L.; Anders, M.W.; Sheu, S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol., 2004, 287(4), C817-833.
30. Poon, H.F.; Calabrese, V.; Scapagnini, G.; Butterfield, D.A. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J. Gerontol. A Biol. Sci. Med. Sci., 2004, 59(5), 478-493.
31. Feissner, R.F.; Skalska, J.; Gaum, W.E.; Sheu, S.S. Crosstalk signaling between mitochondrial Ca2+ and ROS. Front. Biosci., 2009, 14, 1197-1218.
32. Halliwell, B.; Gutteridge, J. Free Radicals in Biology and Medicine, 4th Ed. 2007, Chapter 4: Cellular responses to oxidative stress: adaptation, damage, repair, senscence and death. 2007, 187.
33. Zoratti, M.; Szabo, I. The mitochondrial permeability transition. Biochim. Biophys. Acta, 1995, 1241(2), 139-176.
34. Mahadik, S.P.; Mukherjee, S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr. Res., 1996, 19(1), 1-17.
35. Halliwell, B. Reactive oxygen species and the central nervous system. J. Neurochem., 1992, 59(5), 1609-1623.
36. Halliwell, B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging, 2001, 18(9), 685-716.
37. Shivakumar, B.R.; Anandatheerthavarada, H.K.; Ravindranath, V. Free radical scavenging systems in developing rat brain. Int. J. Dev. Neurosci., 1991, 9(2), 181-185.
38. Coyle, J.T.; Puttfarcken, P. Oxidative stress, glutamate, and neurodegenerative disorders. Science, 1993, 262(5134), 689-695.
39. Sayre, L.M.; Moreira, P.I.; Smith, M.A.; Perry, G. Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita, 2005, 41(2), 143-164.
40. Facchinetti, F.; Dawson, V.L.; Dawson, T.M. Free radicals as mediators of neuronal injury. Cell Mol. Neurobiol., 1998, 18(6), 667-682.
41. Nunomura, A.; Moreira, P.I.; Takeda, A.; Smith, M.A.; Perry, G. Oxidative RNA damage and neurodegeneration. Curr. Med. Chem., 2007, 14(28), 2968-2975.
42. Zeviani, M.; Muntoni, F.; Savarese, N.; Serra, G.; Tiranti, V.; Carrara, F.; Mariotti, C.; DiDonato, S. A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene. Eur. J. Hum. Genet., 1993, 1(1), 80-87.
43. Shoffner, J.M.; Lott, M.T.; Lezza, A.M.; Seibel, P.; Ballinger, S.W.; Wallace, D.C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell, 1990, 61(6), 931-937.
44. Goto, Y.; Nonaka, I.; Horai, S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim. Biophys. Acta, 1991, 1097(3), 238-240.
45. Canafoglia, L.; Franceschetti, S.; Antozzi, C.; Carrara, F.; Farina, L.; Granata, T.; Lamantea, E.; Savoiardo, M.; Uziel, G.; Villani, F.; Zeviani, M.; Avanzini, G. Epileptic phenotypes associated with mitochondrial disorders. Neurology, 2001, 56(10), 1340-1346.
46. Poon, H.F.; Calabrese, V.; Scapagnini, G.; Butterfield, D.A. Free radicals and brain aging. Clin. Geriatr. Med., 2004, 20(2), 329-359.
47. Chamoun, R.; Suki, D.; Gopinath, S.P.; Goodman, J.C.; Robertson, C. Role of extracellular glutamate measured by cerebral microdialysis in severe traumatic brain injury. J. Neurosurg., 2010, 113(3), 564-570.
48. Hatefi, Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu. Rev. Biochem., 1985, 54, 1015-1069.
49. Kudin, A.P.; Zsurka, G.; Elger, C.E.; Kunz, W.S. Mitochondrial involvement in temporal lobe epilepsy. Exp. Neurol., 2009, 218(2), 326-332.
50. Kunz, W.S.; Kudin, A.P.; Vielhaber, S.; Blumcke, I.; Zuschratter, W.; Schramm, J.; Beck, H.; Elger, C.E. Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann. Neurol., 2000, 48(5), 766-773.
51. Lee, Y.M.; Kang, H.C.; Lee, J.S.; Kim, S.H.; Kim, E.Y.; Lee, S.K.; Slama, A.; Kim, H.D. Mitochondrial respiratory chain defects: underlying etiology in various epileptic conditions. Epilepsia, 2008, 49(4), 685-690.
52. Kudin, A.P.; Kudina, T.A.; Seyfried, J.; Vielhaber, S.; Beck, H.; Elger, C.E.; Kunz, W.S. Seizure-dependent modulation of mitochondrial oxidative phosphorylation in rat hippocampus. Eur. J. Neurosci., 2002, 15(7), 1105-1114.
53. Chuang, Y.C.; Chang, A.Y.; Lin, J.W.; Hsu, S.P.; Chan, S.H. Mitochondrial dysfunction and ultrastructural damage in the hippocampus during kainic acid-induced status epilepticus in the rat. Epilepsia, 2004, 45(10), 1202-1209.
54. Sleven, H.; Gibbs, J.E.; Heales, S.; Thom, M.; Cock, H.R. Depletion of reduced glutathione precedes inactivation of mitochondrial enzymes following limbic status epilepticus in the rat hippocampus. Neurochem. Int., 2006, 48(2), 75-82.
55. Fujikawa, D.G.; Shinmei, S.S.; Cai, B. Kainic acid-induced seizures produce necrotic, not apoptotic, neurons with internucleosomal DNA cleavage: implications for programmed cell death mechanisms. Neuroscience, 2000, 98(1), 41-53.
56. Kudin, A.P.; Bimpong-Buta, N.Y.; Vielhaber, S.; Elger, C.E.; Kunz, W.S. Characterization of superoxide-producing sites in isolated brain mitochondria. J. Biol. Chem., 2004, 279(6), 4127-4135.
57. Navarro, A. Mitochondrial enzyme activities as biochemical markers of aging. Mol. Aspects Med., 2004, 25(1-2), 37-48.
58. MacMillan-Crow, L.A.; Crow, J.P.; Thompson, J.A. Peroxynitritemediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry, 1998, 37(6), 1613-1622.
59. Hider, R.C.; Ma, Y.; Molina-Holgado, F.; Gaeta, A.; Roy, S. Iron chelation as a potential therapy for neurodegenerative disease. Biochem. Soc. Trans., 2008, 36(Pt 6), 1304-1308.
60. Pun, P.B.; Lu, J.; Moochhala, S. Involvement of ROS in BBB dysfunction. Free Radic. Res., 2009, 43(4), 348-364.
61. Crompton, M.; Ellinger, H.; Costi, A. Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J., 1988, 255(1), 357-360.
62. Beutner, G.; Ruck, A.; Riede, B.; Welte, W.; Brdiczka, D. Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore. FEBS Lett., 1996, 396(2-3), 189-195.
63. Loeffler, M.; Kroemer, G. The mitochondrion in cell death control: certainties and incognita. Exp. Cell Res., 2000, 256(1), 19-26.
64. Crompton, M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J., 1999, 341 (Pt 2), 233-249.
65. Urbanska, E.M.; Blaszczak, P.; Saran, T.; Kleinrok, Z.; Turski, W.A. Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice. Eur. J. Pharmacol., 1998, 359(1), 55-58.
66. Yamamoto, H. A hypothesis for cyanide-induced tonic seizures with supporting evidence. Toxicology, 1995, 95(1-3), 19-26.
67. Kann, O.; Kovacs, R.; Njunting, M.; Behrens, C.J.; Otahal, J.; Lehmann, T.N.; Gabriel, S.; Heinemann, U. Metabolic dysfunction during neuronal activation in the ex vivo hippocampus from chronic epileptic rats and humans. Brain, 2005, 128(Pt 10), 2396-2407.
68. Kunz, W.S. The role of mitochondria in epileptogenesis. Curr. Opin. Neurol., 2002, 15(2), 179-184.
69. Jarrett, S.G.; Liang, L.P.; Hellier, J.L.; Staley, K.J.; Patel, M. Mitochondrial DNA damage and impaired base excision repair during epileptogenesis. Neurobiol. Dis., 2008, 30(1), 130-138.
70. Junker, H.; Spate, K.; Suofu, Y.; Walther, R.; Schwarz, G.; Kammer, W.; Nordheim, A.; Walker, L.C.; Runge, U.; Kessler, C.; Popa-Wagner, A. Proteomic identification of the involvement of the mitochondrial rieske protein in epilepsy. Epilepsia, 2005, 46(3), 339-343.
71. Margerison, J.H.; Corsellis, J.A. Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain, 1966, 89(3), 499-530.
72. Singh, R.; Pathak, D.N. Lipid peroxidation and glutathione peroxidase, glutathione reductase, superoxide dismutase, catalase, and glucose-6-phosphate dehydrogenase activities in FeCl3-induced epileptogenic foci in the rat brain. Epilepsia, 1990, 31(1), 15-26.
73. Bruce, A.J.; Baudry, M. Oxygen free radicals in rat limbic structures after kainate-induced seizures. Free Radic. Biol. Med., 1995, 18(6), 993-1002.
74. Aytan, N.; Jung, T.; Tamturk, F.; Grune, T.; Kartal-Ozer, N. Oxidative stress related changes in the brain of hypercholesterolemic rabbits. Biofactors, 2008, 33(3), 225-236.
75. Lopez, J.; Gonzalez, M.E.; Lorigados, L.; Morales, L.; Riveron, G.; Bauza, J.Y. Oxidative stress markers in surgically treated patients with refractory epilepsy. Clin. Biochem., 2007, 40(5-6), 292-298.
76. Yis, U.; Seckin, E.; Kurul, S.H.; Kuralay, F.; Dirik, E. Effects of epilepsy and valproic acid on oxidant status in children with idiopathic epilepsy. Epilepsy Res., 2009, 84(2-3), 232-237.
77. Freitas, R.M. Investigation of oxidative stress involvement in hippocampus in epilepsy model induced by pilocarpine. Neurosci. Lett., 2009, 462(3), 225-229.
78. Turkdogan, D.; Toplan, S.; Karakoc, Y. Lipid peroxidation and antioxidative enzyme activities in childhood epilepsy. J. Child Neurol., 2002, 17(9), 673-676.
79. Sudha, K.; Rao, A.V.; Rao, A. Oxidative stress and antioxidants in epilepsy. Clin. Chim. Acta, 2001, 303(1-2), 19-24.
80. Aycicek, A.; Iscan, A. The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children. Eur. Neurol., 2007, 57(2), 65-69.
81. Naziroglu, M.; Kutluhan, S.; Yilmaz, M. Selenium and topiramate modulates brain microsomal oxidative stress values, Ca2+-ATPase activity, and EEG records in pentylentetrazol-induced seizures in rats. J Membr Biol, 2008, 225(1-3), 39-49.
82. Gluck, M.R.; Jayatilleke, E.; Shaw, S.; Rowan, A.J.; Haroutunian, V. CNS oxidative stress associated with the kainic acid rodent model of experimental epilepsy. Epilepsy Res., 2000, 39(1), 63-71.
83. Verrotti, A.; Basciani, F.; Trotta, D.; Pomilio, M.P.; Morgese, G.; Chiarelli, F. Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res., 2002, 48(1-2), 71-75.
84. Gunes, S.; Dirik, E.; Yis, U.; Seckin, E.; Kuralay, F.; Kose, S.; Unalp, A. Oxidant status in children after febrile seizures. Pediatr. Neurol., 2009, 40(1), 47-49.
85. Verrotti, A.; Scardapane, A.; Franzoni, E.; Manco, R.; Chiarelli, F. Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res., 2008, 78(2-3), 171-177.
86. Hamed, S.A.; Abdellah, M.M.; El-Melegy, N. Blood levels of trace elements, electrolytes, and oxidative stress/antioxidant systems in epileptic patients. J. Pharmacol. Sci., 2004, 96(4), 465-473.
87. Solowiej, E.; Sobaniec, W. The effect of antiepileptic drug therapy on antioxidant enzyme activity and serum lipid peroxidation in young patients with epilepsy. Neurol. Neurochir. Pol., 2003, 37(5), 991-1003.
88. Liu, C.S.; Wu, H.M.; Kao, S.H.; Wei, Y.H. Serum trace elements, glutathione, copper/zinc superoxide dismutase, and lipid peroxidation in epileptic patients with phenytoin or carbamazepine monotherapy. Clin. Neuropharmacol., 1998, 21(1), 62-64.
89. Karikas, G.A.; Schulpis, K.H.; Bartzeliotou, A.; Regoutas, S.; Thanopoulou, C.; Papaevangelou, V.; Giannoulia-Karantana, A.; Papassotiriou, I.; Fytou-Pallikari, A. Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities. Scand J. Clin. Lab Invest., 2009, 69(1), 31-35.
90. Schulpis, K.H.; Lazaropoulou, C.; Regoutas, S.; Karikas, G.A.; Margeli, A.; Tsakiris, S.; Papassotiriou, I. Valproic acid monotherapy induces DNA oxidative damage. Toxicology, 2006, 217(2-3), 228-232.
91. Yuksel, A.; Cengiz, M.; Seven, M.; Ulutin, T. Erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children with valproate and carbamazepine monotherapy. J. Basic Clin. Physiol. Pharmacol., 2000, 11(1), 73-81.
92. Niketic, V.; Ristic, S.; Saicic, Z.S.; Spasic, M.; Buzadzic, B.; Stojkovic, M. Activities of antioxidant enzymes and formation of the glutathione adduct of hemoglobin (Hb ASSG) in epileptic patients with long-term antiepileptic therapy. FARMACO, 1995, 50(11), 811-813.
93. Sobaniec, W.; Solowiej, E.; Kulak, W.; Bockowski, L.; Smigielska-Kuzia, J.; Artemowicz, B. Evaluation of the influence of antiepileptic therapy on antioxidant enzyme activity and lipid peroxidation in erythrocytes of children with epilepsy. J. Child Neurol., 2006, 21(7), 558-562.
94. Graf, W.D.; Oleinik, O.E.; Glauser, T.A.; Maertens, P.; Eder, D.N.; Pippenger, C.E. Altered antioxidant enzyme activities in children with a serious adverse experience related to valproic acid therapy. Neuropediatrics, 1998, 29(4), 195-201.
95. Michoulas, A.; Tong, V.; Teng, X.W.; Chang, T.K.; Abbott, F.S.; Farrell, K. Oxidative stress in children receiving valproic acid. J. Pediatr, 2006, 149(5), 692-696.
96. Varoglu, A.O.; Yildirim, A.; Aygul, R.; Gundogdu, O.L.; Sahin, Y.N. Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance. Clin. Neuropharmacol., 2010, 33(3), 155-157.
97. Mahle, C.; Dasgupta, A. Decreased total antioxidant capacity and elevated lipid hydroperoxide concentrations in sera of epileptic patients receiving phenytoin. Life Sci., 1997, 61(4), 437-443.
98. Ono, H.; Sakamoto, A.; Sakura, N. Plasma total glutathione concentrations in epileptic patients taking anticonvulsants. Clin. Chim. Acta, 2000, 298(1-2), 135-143.
99. Yuksel, A.; Cengiz, M.; Seven, M.; Ulutin, T. Changes in the antioxidant system in epileptic children receiving antiepileptic drugs: two-year prospective studies. J. Child Neurol., 2001, 16(8), 603-606.
100. Cengiz, M.; Yuksel, A.; Seven, M. The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children. Pharmacol. Res., 2000, 41(4), 423-425.
101. Arhan, E.; Serdaroglu, A.; Ozturk, B.; Ozturk, H.S.; Ozcelik, A.; Kurt, N.; Kutsal, E.; Sevinc, N. Effects of epilepsy and antiepileptic drugs on nitric oxide, lipid peroxidation and xanthine oxidase system in children with idiopathic epilepsy. Seizure, 2011, 20(2), 138-142.
102. Kurekci, A.E.; Alpay, F.; Tanindi, S.; Gokcay, E.; Ozcan, O.; Akin, R.; Isimer, A.; Sayal, A. Plasma trace element, plasma glutathione peroxidase, and superoxide dismutase levels in epileptic children receiving antiepileptic drug therapy. Epilepsia, 1995, 36(6), 600-604.
103. Karabiber, H.; Yakinci, C.; Durmaz, Y.; Temel, I.; Mehmet, N. Serum nitrite and nitrate levels in epileptic children using valproic acid or carbamazepine. Brain Dev., 2004, 26(1), 15-18.
104. Kupferberg, H. Animal models used in the screening of antiepileptic drugs. Epilepsia, 2001, 42 Suppl 4, 7-12.
105. Safar, M.M.; Abdallah, D.M.; Arafa, N.M.; Abdel-Aziz, M.T. Magnesium supplementation enhances the anticonvulsant potential of valproate in pentylenetetrazol-treated rats. Brain Res., 2010, 1334, 58-64.
106. Johannessen, S.I.; Landmark, C.J. Antiepileptic drug interactions-principles and clinical implications. Curr. Neuropharmacol., 2010, 8(3), 254-267.
107. Ashrafi, M.R.; Shams, S.; Nouri, M.; Mohseni, M.; Shabanian, R.; Yekaninejad, M.S.; Chegini, N.; Khodadad, A.; Safaralizadeh, R. A probable causative factor for an old problem: selenium and glutathione peroxidase appear to play important roles in epilepsy pathogenesis. Epilepsia, 2007, 48(9), 1750-1755.
108. Ozden, H.; Kabay, S.C.; Toker, A.; Ustuner, M.C.; Ozbayer, C.; Ustuner, D.; Gunes, H.V. The effects of levetiracetam on urinary 15f-2t-isoprostane levels in epileptic patients. Seizure, 2010, 19(8), 514-516.
109. Bolayir, E.; Celik, K.; Tas, A.; Topaktas, S.; Bakir, S. The effects of oxcarbazepine on oxidative stress in epileptic patients. Methods Find Exp. Clin. Pharmacol., 2004, 26(5), 345-348.
110. Reiter, R.J.; Tan, D.X.; Sainz, R.M.; Mayo, J.C.; Lopez-Burillo, S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J. Pharm. Pharmacol., 2002, 54(10), 1299-1321.
111. Loscher, W.; Schmidt, D. Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs. Epilepsia, 2006, 47(8), 1253-1284.
112. Bjornsson, E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurol. Scand., 2008, 118(5), 281-290.
113. Lu, W.; Uetrecht, J.P. Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin. Drug Metab. Dispos., 2008, 36(8), 1624-1636.
114. Ezz, H.S.; Khadrawy, Y.A.; Noor, N.A. The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate. Neurochem. Res., 2011, 36(11), 2195-2204.
115. Arora, T.; Mehta, A.K.; Sharma, K.K.; Mediratta, P.K.; Banerjee, B.D.; Garg, G.R.; Sharma, A.K. Effect of carbamazepine and lamotrigine on cognitive function and oxidative stress in brain during chemical epileptogenesis in rats. Basic Clin. Pharmacol. Toxicol., 2010, 106(5), 372-377.
116. Jain, S.; Bharal, N.; Khurana, S.; Mediratta, P.K.; Sharma, K.K. Anticonvulsant and antioxidant actions of trimetazidine in pentylenetetrazole-induced kindling model in mice. Naunyn Schmiedebergs Arch. Pharmacol., 2011, 383(4), 385-392.
117. Naziroglu, M.; Kutluhan, S.; Uguz, A.C.; Celik, O.; Bal, R.; Butterworth, P.J. Topiramate and vitamin e modulate the electroencephalographic records, brain microsomal and blood antioxidant redox system in pentylentetrazol-induced seizure of rats. J. Membr. Biol., 2009, 229(3), 131-140.
118. Imao, K.; Wang, H.; Komatsu, M.; Hiramatsu, M. Free radical scavenging activity of fermented papaya preparation and its effect on lipid peroxide level and superoxide dismutase activity in ironinduced epileptic foci of rats. Biochem. Mol. Biol. Int., 1998, 45(1), 11-23.
119. Kutluhan, S.; Naziroglu, M.; Celik, O.; Yilmaz, M. Effects of selenium and topiramate on lipid peroxidation and antioxidant vitamin levels in blood of pentylentetrazol-induced epileptic rats. Biol. Trace Elem. Res., 2009, 129(1-3), 181-189.
120. Agarwal, N.B.; Agarwal, N.K.; Mediratta, P.K.; Sharma, K.K. Effect of lamotrigine, oxcarbazepine and topiramate on cognitive functions and oxidative stress in PTZ-kindled mice. Seizure, 2011, 20(3), 257-262.
121. Oliveira, A.A.; Almeida, J.P.; Freitas, R.M.; Nascimento, V.S.; Aguiar, L.M.; Junior, H.V.; Fonseca, F.N.; Viana, G.S.; Sousa, F.C.; Fonteles, M.M. Effects of levetiracetam in lipid peroxidation level, nitrite-nitrate formation and antioxidant enzymatic activity in mice brain after pilocarpine-induced seizures. Cell Mol. Neurobiol., 2007, 27(3), 395-406.
122. Willmore, L.J.; Triggs, W.J. Effect of phenytoin and corticosteroids on seizures and lipid peroxidation in experimental posttraumatic epilepsy. J. Neurosurg., 1984, 60(3), 467-472.
123. Mori, A.; Yokoi, I.; Noda, Y.; Willmore, L.J. Natural antioxidants may prevent posttraumatic epilepsy: a proposal based on experimental animal studies. Acta Med. Okayama, 2004, 58(3), 111-118.
124. Komatsu, M.; Hiramatsu, M.; Willmore, L.J. Zonisamide reduces the increase in 8-hydroxy-2'-deoxyguanosine levels formed during iron-induced epileptogenesis in the brains of rats. Epilepsia, 2000, 41(9), 1091-1094.
125. Rauca, C.; Zerbe, R.; Jantze, H. Formation of free hydroxyl radicals after pentylenetetrazol-induced seizure and kindling. Brain Res., 1999, 847(2), 347-351.
126. Turski, W.A.; Cavalheiro, E.A.; Bortolotto, Z.A.; Mello, L.M.; Schwarz, M.; Turski, L. Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res., 1984, 321(2), 237-253.
127. Fernandes, M.J.; Dube, C.; Boyet, S.; Marescaux, C.; Nehlig, A. Correlation between hypermetabolism and neuronal damage during status epilepticus induced by lithium and pilocarpine in immature and adult rats. J. Cereb. Blood Flow Metab., 1999, 19(2), 195-209.
128. Bellissimo, M.I.; Amado, D.; Abdalla, D.S.; Ferreira, E.C.; Cavalheiro, E.A.; Naffah-Mazzacoratti, M.G. Superoxide dismutase, glutathione peroxidase activities and the hydroperoxide concentration are modified in the hippocampus of epileptic rats. Epilepsy Res., 2001, 46(2), 121-128.
129. Motte, J.; Fernandes, M.J.; Baram, T.Z.; Nehlig, A. Spatial and temporal evolution of neuronal activation, stress and injury in lithium-pilocarpine seizures in adult rats. Brain Res., 1998, 793(1-2), 61-72.
130. Pavone, A.; Cardile, V. An in vitro study of new antiepileptic drugs and astrocytes. Epilepsia, 2003, 44 Suppl 10, 34-39.
131. Barres, B.A. Glial ion channels. Curr. Opin. Neurobiol., 1991, 1(3), 354-359.
132. Porter, J.T.; McCarthy, K.D. Astrocytic neurotransmitter receptors in situ and in vivo. Prog Neurobiol, 1997, 51(4), 439-455.
133. Cornell-Bell, A.H.; Finkbeiner, S.M.; Cooper, M.S.; Smith, S.J. Glutamate induces calcium waves in cultured astrocytes: longrange glial signaling. Science, 1990, 247(4941), 470-473.
134. Cardile, V.; Pavone, A.; Renis, M.; Russo, A.; Perciavalle, V. Biological effects of tiagabine on primary cortical astrocyte cultures of rat. Neurosci. Lett., 2000, 288(1), 49-52.
135. Cardile, V.; Pavone, A.; Renis, M.; Maci, T.; Perciavalle, V. Effects of Gabapentin and Topiramate in primary rat astrocyte cultures. Neuroreport, 2001, 12(8), 1705-1708.
136. Wang, J.F.; Azzam, J.E.; Young, L.T. Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells. Neuroscience, 2003, 116(2), 485-489.
137. Cui, J.; Shao, L.; Young, L.T.; Wang, J.F. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience, 2007, 144(4), 1447-1453.